NCT01154816 2020-05-13Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or LeukemiaChildren's Oncology GroupPhase 2 Completed118 enrolled 24 charts
NCT01653028 2017-11-30Alisertib in Treating Patients With Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 2 Completed72 enrolled 13 charts